#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	4460	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2501	531.6	0	.	n	.	0	C1450T	SNP	1450	1450	C	1935	1935	T	675	T	618	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	4460	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2501	531.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1669	1669	C	721	C	622	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6918	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3934	527.9	0	.	n	.	0	T695C	SNP	695	695	T	1246	1246	C	534	C,A	461,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6918	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3934	527.9	0	.	n	.	0	A1638G	SNP	1638	1638	A	2189	2189	G	665	G,A,T	581,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6918	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3934	527.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2522	2522	C	646	C	569	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6918	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3934	527.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2596	2596	A	662	A	573	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6918	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3934	527.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	3148	3148	C	607	C,G	495,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	27	656	folP	852	852	100.0	folP.l15.c4.ctg.1	1829	107.7	1	SNP	p	R228S	0	.	.	682	684	CGC	1155	1157	CGC	153;153;153	C;G;C	132;133;130	folP.WHO_F_01537c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1348	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3757	107.6	1	SNP	p	S91F	0	.	.	271	273	TCC	789	791	TCC	118;117;117	T,A;C,A;C	100,1;103,1;104	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1348	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3757	107.6	1	SNP	p	D95N	0	.	.	283	285	GAC	801	803	GAC	116;115;115	G;A;C	105;106;103	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1348	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3757	107.6	1	SNP	p	D95G	0	.	.	283	285	GAC	801	803	GAC	116;115;115	G;A;C	105;106;103	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	27	604	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1638	110.7	1	SNP	p	G45D	1	.	.	133	135	GAC	623	625	GAC	168;169;169	G;A;C	143;145;145	mtrR.WHO_W_01449:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	408	mtrR_promoter	250	250	99.2	mtrR_promoter.l15.c4.ctg.1	1228	99.6	0	.	n	.	0	T10C	SNP	10	10	T	470	470	C	169	C	146	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	408	mtrR_promoter	250	250	99.2	mtrR_promoter.l15.c4.ctg.1	1228	99.6	0	.	n	.	0	A197.	DEL	197	197	A	656	656	A	177	A	153	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1304	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3270	119.6	0	.	p	.	0	V384I	NONSYN	1150	1152	GTC	1603	1605	ATC	168;168;166	A;T;C	146;145;145	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1304	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3270	119.6	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1756	1758	GCA	156;155;155	G;C;A	129;125;128	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1304	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3270	119.6	0	.	p	.	0	V596I	NONSYN	1786	1788	GTT	2239	2241	ATT	133;133;133	A;T;T	119;115;121	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1304	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3270	119.6	1	SNP	p	D86N	0	.	.	256	258	GAC	709	711	GAC	133;132;132	G;A,C;C	115;117,1;119	parC.WHO_F_01444:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1304	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3270	119.6	1	SNP	p	S87I	0	.	.	259	261	AGT	712	714	AGT	131;130;129	A;G;T	117;117;118	parC.WHO_F_01444:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1304	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3270	119.6	1	SNP	p	S87W	0	.	.	259	261	AGT	712	714	AGT	131;130;129	A;G;T	117;117;118	parC.WHO_F_01444:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1304	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3270	119.6	1	SNP	p	S87R	0	.	.	259	261	AGT	712	714	AGT	131;130;129	A;G;T	117;117;118	parC.WHO_F_01444:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1304	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3270	119.6	1	SNP	p	S88P	0	.	.	262	264	TCC	715	717	TCC	129;129;128	T;C,A;C	115;117,1;117	parC.WHO_F_01444:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1230	parE	1986	1986	100.0	parE.l15.c30.ctg.1	2995	123.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1713	1715	GGC	156;156;155	G;G;C	137;137;135	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.22.001	penA.22.001	1	1	27	1344	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2737	147.3	1	SNP	p	A311V	0	.	.	931	933	GCA	1422	1424	GCA	196;197;198	G;C,G;A	172;170,1;176	penA.22.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	1344	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2737	147.3	1	SNP	p	I312M	0	.	.	934	936	ATC	1425	1427	ATC	198;199;198	A;T;C,T	169;171;172,1	penA.22.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	1344	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2737	147.3	1	SNP	p	V316P	0	.	.	946	948	GTG	1437	1439	GTG	200;200;200	G;T;G	175;174;176	penA.22.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	1344	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2737	147.3	1	SNP	p	V316T	0	.	.	946	948	GTG	1437	1439	GTG	200;200;200	G;T;G	175;174;176	penA.22.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	1344	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2737	147.3	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1941	1943	ACC	203;203;204	A,G;C;C	178,1;183;181	penA.22.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	1344	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2737	147.3	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1995	1997	GCG	196;196;196	G;C,G;G,A	177;159,1;166,1	penA.22.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	1344	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2737	147.3	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1995	1997	GCG	196;196;196	G;C,G;G,A	177;159,1;166,1	penA.22.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	1344	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2737	147.3	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2118	2120	GGT	174;173;173	G,A;G;T	148,1;151;149	penA.22.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	1344	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2737	147.3	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2127	2129	GGC	172;173;171	G;G;C	146;144;144	penA.22.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	1344	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2737	147.3	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2145	2147	CCG	173;175;175	C;C;G	139;147;143	penA.22.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1452	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3381	128.5	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1739	1741	CCG	114;114;114	C;C;G	100;98;101	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1404	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2010	209.0	0	.	p	.	0	S22G	NONSYN	64	66	AGC	508	510	GGC	260;258;259	G;G,T;C,T	214;207,1;213,1	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1404	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2010	209.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	690	690	C	264	C	232	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	964	porB1b	1047	1047	99.81	porB1b.l15.c4.ctg.1	1905	151.2	0	.	p	.	0	G120D	NONSYN	358	360	GGC	819	821	GAC	197;194;193	G;A;C	170;169;164	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	964	porB1b	1047	1047	99.81	porB1b.l15.c4.ctg.1	1905	151.2	1	SNP	p	D121N	1	D121N	NONSYN	361	363	GAC	822	824	AAC	192;192;192	A;A;C	168;169;169	porB1b.WHO_P_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	3054	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5118	178.9	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2146	2148	CAT	191;190;190	C;A;T	161;161;159	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	466	rpsJ	312	312	100.0	rpsJ.l6.c17.ctg.1	1294	108.1	1	SNP	p	V57M	1	.	.	169	171	ATG	643	645	ATG	191;190;191	A;T;G	166;162;167	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
